IMMUNOCORE HOLDINGS PLC

Profile

Company Names

IMMUNOCORE HOLDINGS PLC

Addresses

92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, X0 OX14 4RY

Phone Numbers

+44 1235 438600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

UNITED KINGDOM

Total Amount Raised:

$139,999,988.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-07-20 
$139,999,988.00 
$139,999,988.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
BELL 
DIRECTOR
JENNEREX, INC.   |  SOURCE ROCK ROYALTIES LTD.   |  CULTIVATE MUSIC, INC.   |  GESTALT DIAGNOSTICS, LLC   |  CURE PHARMACEUTICAL HOLDING CORP.   |  PRIMETIME HOLDINGS INC.   |  IMMUNOCORE HOLDINGS PLC   |  NEVIS BRANDS INC.   |  TAMBORAN RESOURCES CORP
DAVID 
 
BERMAN 
EXECUTIVE OFFICER
EGENIO EDUCATION SOLUTIONS LLC   |  ULTIMATE PROS, LLC   |  AFFECTIVA, INC.   |  TRICON XI A, L.P.   |  TRICON AMERICAN HOMES LLC   |  TRICON CAPITAL GROUP INC.   |  TRICON XI B, L.P.   |  TRICON XI B-2, L.P.   |  TRICON MANUFACTURED HOUSING COMMUNITIES LLC   |  FIRST SENSE MEDICAL, LLC   |  BREAKING DATA CORP.   |  HEMOSTEMIX INC.   |  LORIENT HEALTHCARE FUND, LP   |  LORIENT HEALTHCARE PARALLEL FUND, LP   |  SFR JV-1 CLASS B REIT LLC   |  LORIENT HEALTHCARE FUND II, LP   |  TRANSITIONS ACQUISITION, LP   |  LORIENT PET SERVICES, LLC   |  LORIENT VBF CO-INVEST, LP   |  LORIENT HEALTHCARE GP II INVESTMENT, LP   |  LORIENT SHIFTKEY INVESTMENT, LP   |  LORIENT SHIFTKEY BLOCKER, LLC   |  LORIENT HEALTHCARE PARALLEL FUND II, LP   |  LORIENT EAGLE INVESTMENT GP, LP   |  LORIENT EAGLE INVESTMENT, LP   |  THP JV-1C LLC   |  IMMUNOCORE HOLDINGS PLC   |  LORIENT PEREGRINE INVESTMENT, LP   |  LORIENT PEREGRINE GP INVESTMENT, LP   |  ZENSUPPLY INC.   |  LORIENT HEALTHCARE GP III INVESTMENT, LP   |  LORIENT HEALTHCARE FUND III, LP   |  BERMAN MEDICAL, INC.
TRAVIS 
 
COY 
DIRECTOR
IMMUNOCORE HOLDINGS PLC   |  TREX HOLDINGS INC.
BRIAN 
 
DI DONATO 
EXECUTIVE OFFICER
IMMUNOCORE HOLDINGS PLC
ROY 
 
HERBST 
DIRECTOR
IMMUNOCORE HOLDINGS PLC
BAHIJA 
 
JALLAL 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOCORE HOLDINGS PLC   |  ARRIVENT BIOPHARMA, INC.   |  OUTPACE BIO, INC.
SIDDHARTH 
 
KAUL 
DIRECTOR
IMMUNOCORE HOLDINGS PLC
ROBERT 
 
PEREZ 
DIRECTOR
VIR BIOTECHNOLOGY, INC.   |  AKILI INTERACTIVE LABS, INC.   |  IMMUNOCORE HOLDINGS PLC
KRISTINE 
 
PETERSON 
DIRECTOR
VALERITAS INC   |  EYEPOINT PHARMACEUTICALS, INC.   |  IMMUNOCORE HOLDINGS PLC
PETER 
 
RATCLIFFE 
DIRECTOR
IMMUNOCORE HOLDINGS PLC
TINA 
 
ST. LEGER 
EXECUTIVE OFFICER
IMMUNOCORE HOLDINGS PLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-07-28
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-07-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#